SIMG
TNDM icon

Stephens Investment Management Group’s Tandem Diabetes Care TNDM Stock Holding History

Stephens Investment Management Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,737,769
Closed -$32.4M – 187
2025
Q2 		$32.4M Buy
1,737,769
+30,854
+2% +$611K 0.43% 96
2025
Q1 		$32.7M Buy
1,706,915
+151,106
+10% +$4.42M 0.47% 88
2024
Q4 		$56M Buy
1,555,809
+281,327
+22% +$9.52M 0.75% 54
2024
Q3 		$54.1M Buy
1,274,482
+138,263
+12% +$5.86M 0.74% 55
2024
Q2 		$45.8M Buy
1,136,219
+173,660
+18% +$7.24M 0.64% 69
2024
Q1 		$34.1M Buy
962,559
+287
+0% +$7.69K 0.45% 93
2023
Q4 		$28.5M Sell
962,272
-26,823
-3% -$556K 0.42% 97
2023
Q3 		$20.5M Sell
989,095
-21,486
-2% -$590K 0.34% 102
2023
Q2 		$24.8M Sell
1,010,581
-19,416
-2% -$625K 0.39% 104
2023
Q1 		$41.8M Buy
1,029,997
+46,846
+5% +$1.94M 0.7% 68
2022
Q4 		$42.3M Buy
983,151
+3,555
+0.4% +$161K 0.77% 62
2022
Q3 		$46.9M Buy
979,596
+141,168
+17% +$7.74M 0.89% 42
2022
Q2 		$49.6M Buy
838,428
+4,459
+0.5% +$366K 0.92% 39
2022
Q1 		$97M Buy
833,969
+14,354
+2% +$1.68M 1.42% 6
2021
Q4 		$123M Sell
819,615
-731
-0.1% -$98.7K 1.59% 5
2021
Q3 		$97.9M Buy
820,346
+41,424
+5% +$4.56M 1.33% 10
2021
Q2 		$75.9M Buy
778,922
+107,600
+16% +$9.59M 1.04% 25
2021
Q1 		$59.2M Buy
671,322
+84,816
+14% +$7.88M 0.86% 46
2020
Q4 		$56.1M Sell
586,506
-13,478
-2% -$1.39M 0.83% 50
2020
Q3 		$68.1M Sell
599,984
-19,140
-3% -$2.01M 1.2% 18
2020
Q2 		$61.2M Buy
619,124
+53,112
+9% +$4.24M 1.11% 27
2020
Q1 		$36.4M Sell
566,012
-7,678
-1% -$538K 0.88% 52
2019
Q4 		$34.2M Buy
573,690
+75,663
+15% +$4.67M 0.64% 74
2019
Q3 		$29.4M Buy
498,027
+366,152
+278% +$23.4M 0.59% 77
2019
Q2 		$8.51M Buy
+131,875
New +$8.51M 0.16% 138

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stephens Investment Management Group's TNDM Position: Q3 2025 in Review

Stephens Investment Management Group sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 1,737,769 shares — an estimated $32.4M sold.

Stephens Investment Management Group first reported a position in TNDM in Q2 2019 and held it in 25 quarters. The position peaked at $123M in Q4 2021. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Stephens Investment Management Group reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Stephens Investment Management Group sold 1,737,769 Tandem Diabetes Care shares in Q3 2025, an estimated $32.4M.
  • Stephens Investment Management Group first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 25 quarters.
  • Stephens Investment Management Group's Tandem Diabetes Care position peaked at $123M in Q4 2021.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Stephens Investment Management Group's 13F filing for Q3 2025, filed 28 Oct 2025.